| 缩写名/全名 |
J GASTROEN HEPATOL
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
||||||||||||||||||||
| ISSN号 | 0815-9319 | ||||||||||||||||||||
| 研究方向 | 医学-胃肠肝病学 | ||||||||||||||||||||
| 影响因子 | 2015:3.322, 2016:3.452, 2017:3.483, 2018:3.632, 2019:3.437, | ||||||||||||||||||||
| 出版国家 | AUSTRALIA | ||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||
| 年文章数 | 265 | ||||||||||||||||||||
| 出版年份 | 1986 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 平均2.3月 |
||||||||||||||||||||
| 录用比例 | 约62.5% | ||||||||||||||||||||
| 投稿链接 | http://mc.manuscriptcentral.com/jgh | ||||||||||||||||||||
| 投稿官网 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1746 | ||||||||||||||||||||
| h-index | 117 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0815-9319%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | N-myc and STAT interactor correlates with severity and prognosis in acute-on-chronic liver failure of hepatitis B virus. Author: Xiong L1, Du Y1, Zhou T1, Du B1, Visalath P1, Lin L1, Bao S2, Cai W1. Journal: J Gastroenterol Hepatol. 2019 Feb 16. doi: 10.1111/jgh.14634. [Epub ahead of print] PubMed DOI |
| 2. | Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection. Author: Wei L1, Kumada H2, Perumalswami PV3, Tanwandee T4, Cheng W5, Heo J6, Cheng PN7, Hwang P8, Mu SM9, Zhao XM9, Asante-Appiah E8, Caro L8, Hanna GJ8, Robertson MN8, Haber BA8, Talwani R8. Journal: J Gastroenterol Hepatol. 2019 Feb 19. doi: 10.1111/jgh.14636. [Epub ahead of print] PubMed DOI |
| 3. | MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3. Author: Peng C1, Huang K1, Liu G1, Li Y1, Yu C1. Journal: J Gastroenterol Hepatol. 2019 Mar 6. doi: 10.1111/jgh.14649. [Epub ahead of print] PubMed DOI |
| 4. | Best practices on immunomodulators and biological agents for Ulcerative colitis and Crohn's disease in Asia. Author: Ooi CJ1, Hilmi I2, Banerjee R3, Chuah SW4, Ng SC5, Wei SC6, Makharia GK7, Pisespongsa P8, Chen MH9, Ran ZH10, Ye BD11, Park DI12, Ling KL13, Ong D14, Ahuja V7, Goh KL15, Sollano J16, Lim WC17, Leung WK18, Raja Ali RA19, Wu DC20, Ong E16, Mustaffa N21, Limsrivilai J22, Hisamatsu T23, Yang SK24, Ouyang Q25, Geary R26, De Silva JH27, Rerknimitr R28, Simadibrata M29, Abdullah M30, Leong RWL31; Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn's and Colitis. Journal: J Gastroenterol Hepatol. 2019 Mar 8. doi: 10.1111/jgh.14648. [Epub ahead of print] PubMed DOI |
| 5. | Utility of the EncephalApp Stroop Test for covert hepatic encephalopathy screening in Chinese cirrhotic patients. Author: Zeng X1, Li XX2, Shi PM1, Zhang YY2, Song Y2, Liu Q2, Wei L2, Bajaj JS3, Zhu YH4, Li Y4, Gu Y4, Xie WF1, Liu YL2. Journal: J Gastroenterol Hepatol. 2019 Mar 12. doi: 10.1111/jgh.14656. [Epub ahead of print] PubMed DOI |
| 6. | Pancreatic liposarcoma: A rare cause of pancreatic mass in adult. Author: Cao D1, Wang J1, Guo L2. Journal: J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14621. [Epub ahead of print] PubMed DOI |
| 7. | Prevalence of pancreatic cystic lesions detected by magnetic resonance imaging in the Chinese population. Author: Sun L1, Wang Y2, Jiang F1, Qian W1, Shao C2, Jin Z1. Journal: J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14658. [Epub ahead of print] PubMed DOI |
| 8. | Establishment of gene-edited pigs expressing human blood-coagulation factor VII and albumin for bioartificial liver use. Author: Li L1, Meng H1, Zou Q2, Zhang J1, Cai L1, Yang B1, Weng J1, Lai L3, Yang H4, Gao Y1. Journal: J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14666. [Epub ahead of print] PubMed DOI |
| 9. | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. Author: Liu CH1,2,3, Shih YL4, Yang SS5,6,7, Lin CL8, Fang YJ3, Cheng PN9, Chen CY10, Peng CY11, Hsieh TY4, Chiu YC9, Su TH1,2, Liu CJ1,2, Yang HC12, Chen PJ1,2,13, Chen DS1,2,14, Kao JH1,2,13. Journal: J Gastroenterol Hepatol. 2019 Apr 1. doi: 10.1111/jgh.14672. [Epub ahead of print] PubMed DOI |
| 10. | A new substage classification strategy for Barcelona Clinic Liver Cancer stage B patients with hepatocellular carcinoma. Author: Hu KS1,2, Tang B1,2, Yuan J1,2, Lu SX1,2, Li M1,2, Chen RX1,2, Zhang L1,2, Ren ZG1,2, Yin X1,2. Journal: J Gastroenterol Hepatol. 2019 Apr 1. doi: 10.1111/jgh.14673. [Epub ahead of print] PubMed DOI |
|
|
